|
1
|
Smith RA, Andrews K, Brooks D, DeSantis
CE, Fedewa SA, Lortet-Tieulent J, Manassaram-Baptiste D, Brawley OW
and Wender RC: Cancer screening in the United States, 2016: A
review of current American cancer society guidelines and current
issues in cancer screening. CA Cancer J Clin. 66:96–114. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller SM, Goulet DR and Johnson GL:
Targeting the breast cancer kinome. J Cell Physiol. 232:53–60.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anastasiadi Z, Lianos GD, Ignatiadou E,
Harissis HV and Mitsis M: Breast cancer in young women: An
overview. Updates Surg. 69:313–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simmons A, Burrage PM, Nicolau DV Jr,
Lakhani SR and Burrage K: Environmental factors in breast cancer
invasion: A mathematical modelling review. Pathology. 49:172–180.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou H, Xu M, Gao Y, Deng Z, Cao H, Zhang
W, Wang Q, Zhang B, Song G, Zhan Y and Hu T: Matrine induces
caspase-independent program cell death in hepatocellular carcinoma
through bid-mediated nuclear translocation of apoptosis inducing
factor. Mol Cancer. 13:592014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J,
Zhang S, Wu J, Yu K and Han Y: Matrine induces apoptosis in human
acute myeloid leukemia cells via the mitochondrial pathway and Akt
Inactivation. PLoS One. 7:e468532012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meng F, Wang J, Ding F, Xie Y, Zhang Y and
Zhu J: Neuroprotective effect of matrine on MPTP-induced
Parkinson's disease and on Nrf2 expression. Oncol Lett. 13:296–300.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu
XS, Xu XR, Liu BZ and He YJ: Effects of matrine on proliferation
and differentiation in K-562 cells. Leuk Res. 25:793–800. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Long Y, Lin XT, Zeng KL and Zhang L:
Efficacy of intramuscular matrine in the treatment of chronic
hepatitis B. Hepatobiliary Pancreat Dis Int. 3:69–72.
2004.PubMed/NCBI
|
|
11
|
Sciacovelli M and Frezza C: Metabolic
reprogramming and epithelial-to-mesenchymal transition in cancer.
FEBS J. 284:3132–3144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Klahan S, Huang WC, Chang CM, Wong HS,
Huang CC, Wu MS, Lin YC, Lu HF, Hou MF and Chang WC: Gene
expression profiling combined with functional analysis identify
integrin beta1 (ITGB1) as a potential prognosis biomarker in triple
negative breast cancer. Pharmacol Res. 104:31–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zawistowski JS, Nakamura K, Parker JS,
Granger DA, Golitz BT and Johnson GL: MicroRNA 9-3p targets β1
integrin to sensitize claudin-low breast cancer cells to MEK
inhibition. Mol Cell Biol. 33:2260–2274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu J, Hu G, Dong Y, Ma R, Yu Z, Jiang S,
Han Y, Yu K and Zhang S: Matrine induces Akt/mTOR signalling
inhibition-mediated autophagy and apoptosis in acute myeloid
leukaemia cells. J Cell Mol Med. 21:1171–1181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma K, Huang MY, Guo YX and Hu GQ:
Matrine-induced autophagy counteracts cell apoptosis via the ERK
signaling pathway in osteosarcoma cells. Oncol Lett. 12:1854–1860.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qu X, Sheng J, Shen L, Su J, Xu Y, Xie Q,
Wu Y, Zhang X and Sun L: Autophagy inhibitor chloroquine increases
sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by
mitochondrial ROS. PLoS One. 12:e01737122017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuo S-H, Tang G, Ma K, Babij R, Cortes E,
Vonsattel JP, Faust PL, Sulzer D and Louis ED: Macroautophagy
abnormality in essential tremor. PLoS One. 7:e530402012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Talmadge JE and Fidler IJ: AACR centennial
series: The biology of cancer metastasis: Historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li WX, Sha RL, Bao JQ, Luan W, Su RL and
Sun SR: Expression of long non-coding RNA linc-ITGB1 in breast
cancer and its influence on prognosis and survival. Eur Rev Med
Pharmacol Sci. 21:3397–3401. 2017.PubMed/NCBI
|
|
21
|
Xie G, Ji A, Yuan Q, Jin Z, Yuan Y, Ren C,
Guo Z, Yao Q, Yang K, Lin X and Chen L: Tumour-initiating capacity
is independent of epithelial-mesenchymal transition status in
breast cancer cell lines. Br J Cancer. 110:2514–2523. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Li X, Bai M, Suo Y, Zhang G and Cao
X: Matrine inhibited proliferation and increased apoptosis in human
breast cancer MCF-7 cells via upregulation of Bax and
downregulation of Bcl-2. Int J Clin Exp Pathol. 8:14793–14799.
2015.PubMed/NCBI
|
|
23
|
Chen F and Huang K: Effects of the Chinese
medicine matrine on experimental C. parvum infection in BALB/c mice
and MDBK cells. Parasitol Res. 111:1827–1832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shao H, Yang B, Hu R and Wang Y: Matrine
effectively inhibits the proliferation of breast cancer cells
through a mechanism related to the NF-κB signaling pathway. Oncol
Lett. 6:517–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang
HH, Liu X, Liang DS, Lu YJ, Shan HL and Jiang HC: Matrine inhibits
breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells.
Cell Physiol Biochem. 30:631–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang H, Hou C, Zhang S, Xie H, Zhou W,
Jin Q, Cheng X, Qian R and Zhang X: Matrine upregulates the cell
cycle protein E2F-1 and triggers apoptosis via the mitochondrial
pathway in K562 cells. Eur J Pharmacol. 559:98–108. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu KY, Wang YP, Wang LH, Jian Y, Zhao XD,
Chen JW, Murao K, Zhu W, Dong L, Wang GQ and Zhang GX:
Mitochondrial KATP channel involvement in angiotensin II-induced
autophagy in vascular smooth muscle cells. Basic Res Cardiol.
109:4162014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu X, Zhou J, Cai D and Li M: Matrine
inhibits the metastatic properties of human cervical cancer cells
via downregulating the p38 signaling pathway. Oncol Rep.
38:1312–1320. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan
H, Luan G, Yagasaki K and Zhang G: Effects of matrine against the
growth of human lung cancer and hepatoma cells as well as lung
cancer cell migration. Cytotechnology. 59:191–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Wang T, Wen X, Wei Y, Peng X, Li
H and Wei L: Effect of matrine on HeLa cell adhesion and migration.
Eur J Pharmacol. 563:69–76. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hynes RO: Integrins: Bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu Z, Zou L, Ma G, Wu X, Huang F, Feng T,
Li S, Lin Q, He X, Liu Z and Cao X: Integrin β1 is a critical
effector in promoting metastasis and chemo-resistance of esophageal
squamous cell carcinoma. Am J Cancer Res. 7:531–542.
2017.PubMed/NCBI
|
|
33
|
Jahangiri A, Nguyen A, Chandra A, Sidorov
MK, Yagnik G, Rick J, Han SW, Chen W, Flanigan PM,
Schneidman-Duhovny D, et al: Cross-activating c-Met/β1 integrin
complex drives metastasis and invasive resistance in cancer. Proc
Natl Acad Sci USA. 114:E8685–E8694. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang R, Zhang C, Liu G, Gu R and Wu H:
MicroRNA-126 inhibits proliferation, migration, invasion and EMT in
osteosarcoma by targeting ZEB1. J Cell Biochem. 118:3765–3774.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Araki K, Shimura T, Suzuki H, Tsutsumi S,
Wada W, Yajima T, Kobayahi T, Kubo N and Kuwano H: E/N-cadherin
switch mediates cancer progression via TGF-β-induced
epithelial-to-mesenchymal transition in extrahepatic
cholangiocarcinoma. Br J Cancer. 105:1885–1893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Hao Y, Mao W, Xue X, Xu P, Liu L,
Yuan J, Zhang D, Li N, Chen H, et al: LincK contributes to breast
tumorigenesis by promoting proliferation and
epithelial-to-mesenchymal transition. J Hematol Oncol. 12:192019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Zhao J, Zhang PY, Zhang Y, Sun SY,
Yu SY and Xi QS: MicroRNA-10b targets E-cadherin and modulates
breast cancer metastasis. Med Sci Monit. 18:BR299–BR308. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ding Y, Pan Y, Liu S, Jiang F and Jiao J:
Elevation of MiR-9-3p suppresses the epithelial-mesenchymal
transition of nasopharyngeal carcinoma cells via down-regulating
FN1, ITGB1 and ITGAV. Cancer Biol Ther. 18:414–424. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang YY, Kong LQ, Zhu XD, Cai H, Wang CH,
Shi WK, Cao MQ, Li XL, Li KS, Zhang SZ, et al: CD31 regulates
metastasis by inducing epithelial-mesenchymal transition in
hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway.
Cancer Lett. 429:29–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang J, Hou Y, Zhou M, Wen S, Zhou J, Xu
L, Tang X, Du YE, Hu P and Liu M: Twist induces
epithelial-mesenchymal transition and cell motility in breast
cancer via ITGB1-FAK/ILK signaling axis and its associated
downstream network. Int J Biochem Cell Biol. 71:62–71. 2016.
View Article : Google Scholar : PubMed/NCBI
|
